)
Rhythm Pharmaceuticals (RYTM) investor relations material
Rhythm Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 24, 2026, at 2:00 PM ET, conducted virtually via live webcast.
Proxy materials and 2025 Annual Report are available online for review and voting.
Shareholders are encouraged to access materials electronically to support environmental initiatives.
Voting matters and shareholder proposals
Election of two Class III directors, David W.J. McGirr and David P. Meeker, M.D., for three-year terms until the 2029 annual meeting.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory (non-binding) vote on the compensation of named executive officers.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and FOR both other proposals.
- Q1 2026 revenue rose 59% to $60.1M, with global IMCIVREE expansion and higher operating loss.RYTM
Q1 20265 May 2026 - Proxy covers director elections, auditor ratification, Say-on-Pay, and robust ESG and compensation practices.RYTM
Proxy filing29 Apr 2026 - IMCIVREE launches in HO, with global expansion and pivotal PWS data expected mid-year.RYTM
25th Annual Needham Virtual Healthcare Conference16 Apr 2026 - FDA approves IMCIVREE as the first therapy for acquired hypothalamic obesity after strong Phase 3 results.RYTM
Study update20 Mar 2026 - Post hoc analyses showed significant BMI reductions in POMC/PCSK1 and SRC1 cohorts.RYTM
Study result17 Mar 2026 - Major HO launch set for March, with global expansion and next-gen therapies driving growth.RYTM
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - IMCIVREE sales surged 50% in 2025, with key regulatory and clinical milestones ahead in 2026.RYTM
Q4 202526 Feb 2026 - Strong clinical and commercial momentum positions IMCIVREE for significant growth in rare obesity disorders.RYTM
Guggenheim Securities Emerging Outlook: Biotech Summit 202611 Feb 2026 - Q2 revenue up 51–52% to $29.1M; strong cash reserves fund operations into 2026.RYTM
Q2 20242 Feb 2026
Next Rhythm Pharmaceuticals earnings date
Next Rhythm Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)